Last updated July 12, 2026
Key finding
Glucose levels at 60 min were higher after PE (136 ± 35.2 mg/dL vs. 124 ± 32.2 mg/dL, p = 0.016).
This study evaluated two advanced insulin dosing algorithms for managing postprandial glucose levels in adolescents with Type 1 Diabetes, finding significant differences in glucose levels but no impact on hypoglycemic episodes.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Extended (5–20+ y)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This study evaluated two advanced insulin dosing algorithms for managing postprandial glucose levels in adolescents with Type 1 Diabetes, finding significant differences in glucose levels but no impact on hypoglycemic episodes.
Understanding the effectiveness of different insulin dosing algorithms is crucial for optimizing diabetes management in adolescents. Improved postprandial control can enhance overall glycemic management and reduce the risk of hypoglycemic events, which are critical for patient safety and quality of life.
Limited sample size may affect the generalizability of findings. The study only included adolescents, limiting applicability to other age groups. No long-term follow-up data were provided to assess sustained effectiveness.
Published in
Publication details and source links for this paper.
Magdalena D, Emilia K, Katarzyna P, Agnieszka S, Clive JP. Evaluation of Two Advanced Insulin Dosing Algorithms for Postprandial Control in Adolescents with Type 1 Diabetes. Nutrients. 2025;17(20):3287. doi:10.3390/nu17203287
Glucose levels at 60 min were higher after PE (136 ± 35.2 mg/dL) compared to SE (124 ± 32.2 mg/dL, p = 0.016).
Fewer hypoglycemic episodes at 180 min were observed with SE compared to PE.
No significant differences in glycemic variability parameters were reported.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Sieradzki Equation for Insulin Dosing and Frequency of hypoglycemic episodes at 180 minutes, Glucose iAUC (OGTT), Glucose variability.
This study contributes evidence to
Primary intervention
Sieradzki Equation for Insulin Dosing
Primary outcomes
Evidence topics
Primary intervention
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
1
Related topics
3
Evidence pairs
171
Related studies
Evidence topic
Contributes evidence
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence topic
matched_outcome
Core evidence
The primary outcomes reported in this study.
Sieradzki Equation for Insulin Dosing → Frequency of hypoglycemic episodes at 180 minutes
Sieradzki Equation for Insulin Dosing → Frequency of hypoglycemic episodes at 180 minutes
Sieradzki Equation for Insulin Dosing → Glucose iAUC (OGTT)
Sieradzki Equation for Insulin Dosing → Glucose iAUC (OGTT)
Sieradzki Equation for Insulin Dosing → Glucose variability
Sieradzki Equation for Insulin Dosing → Glucose variability
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Sieradzki Equation for Insulin Dosing and Frequency of hypoglycemic episodes at 180 minutes, Sieradzki Equation for Insulin Dosing and Postprandial and OGTT Glucose.
This study contributes to the evidence on the following intervention-outcome relationships.
Medications
Curated evidence collections and hubs this study is part of.
All studies measuring Frequency of hypoglycemic episodes at 180 minutes
Measures Frequency of hypoglycemic episodes at 180 minutes as a key outcome.
All studies measuring Postprandial and OGTT Glucose
Measures Postprandial and OGTT Glucose as a key outcome.
All studies on Sieradzki Equation for Insulin Dosing
Contributes to Sieradzki Equation for Insulin Dosing evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Current evidence does not show a clear benefit of Sieradzki Equation for Insulin Dosing for Frequency of hypoglycemic episodes at 180 minutes.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Frequency of hypoglycemic episodes at 180 minutes
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Sieradzki Equation for Insulin Dosing for Glucose variability.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Glucose variability
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Sieradzki Equation for Insulin Dosing may worsen Glucose iAUC (OGTT) or be associated with harm.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Glucose iAUC (OGTT)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | moderate negative | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.
